{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:30:41Z","timestamp":1792477841738,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11637-9","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:20:22Z","timestamp":1782858022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design, synthesis, and biological evaluation of novel isobenzofuran-1(3H)-one derivatives with antioxidant properties and improved oral bioavailability"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4018-0793","authenticated-orcid":false,"given":"Debasis","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhe","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"11637_CR1","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.3390\/molecules28248038","volume":"28","author":"M Stielow","year":"2023","unstructured":"Stielow M, Witczy\u0144ska A, Kubry\u0144 N et al (2023) The bioavailability of drugs-the current state of knowledge. Molecules 28:8038. https:\/\/doi.org\/10.3390\/molecules28248038","journal-title":"Molecules"},{"key":"11637_CR2","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC (2005) A bioavailability score. J Med Chem 48:3164\u20133170. https:\/\/doi.org\/10.1021\/jm0492002","journal-title":"J Med Chem"},{"key":"11637_CR3","doi-asserted-by":"publisher","first-page":"13121","DOI":"10.3390\/ijms252313121","volume":"25","author":"K Wu","year":"2024","unstructured":"Wu K, Kwon SH, Zhou X et al (2024) Overcoming challenges in small-molecule drug bioavailability: a review of key factors and approaches. IJMS 25:13121. https:\/\/doi.org\/10.3390\/ijms252313121","journal-title":"IJMS"},{"key":"11637_CR4","doi-asserted-by":"publisher","unstructured":"Bhalani DV, Nutan B, Kumar A, Singh Chandel AK (2022) Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines 10:2055. https:\/\/doi.org\/10.3390\/biomedicines10092055","DOI":"10.3390\/biomedicines10092055"},{"key":"11637_CR5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ajps.2014.05.005","volume":"9","author":"P Khadka","year":"2014","unstructured":"Khadka P, Ro J, Kim H et al (2014) Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9:304\u2013316. https:\/\/doi.org\/10.1016\/j.ajps.2014.05.005","journal-title":"Asian J Pharm Sci"},{"key":"11637_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/molecules21010042","volume":"21","author":"DH Jornada","year":"2015","unstructured":"Jornada DH, dos Santos Fernandes GF, Chiba DE et al (2015) The prodrug approach: a successful tool for improving drug solubility. Molecules 21:42. https:\/\/doi.org\/10.3390\/molecules21010042","journal-title":"Molecules"},{"key":"11637_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1208\/s12249-025-03287-1","volume":"27","author":"AF P\u00e9rez Palacios","year":"2025","unstructured":"P\u00e9rez Palacios AF, Medina Parra JA, C\u00f3rdoba Velasco DS et al (2025) New Strategies to improve drug solubility and its impact on bioavailability: a patent review (2015\u20132024). AAPS PharmSciTech 27:57. https:\/\/doi.org\/10.1208\/s12249-025-03287-1","journal-title":"AAPS PharmSciTech"},{"key":"11637_CR8","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"M Schieber","year":"2014","unstructured":"Schieber M, Chandel NS (2014) ROS function in redox signaling and oxidative stress. Curr Biol 24:R453\u2013462. https:\/\/doi.org\/10.1016\/j.cub.2014.03.034","journal-title":"Curr Biol"},{"key":"11637_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DSA Simpson","year":"2020","unstructured":"Simpson DSA, Oliver PL (2020) ROS Generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxid (Basel) 9:743. https:\/\/doi.org\/10.3390\/antiox9080743","journal-title":"Antioxid (Basel)"},{"key":"11637_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","volume":"54","author":"L Pu","year":"2023","unstructured":"Pu L, Wang L, Zhang R et al (2023) Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030. Stroke 54:1330\u20131339. https:\/\/doi.org\/10.1161\/STROKEAHA.122.040073","journal-title":"Stroke"},{"key":"11637_CR11","doi-asserted-by":"publisher","first-page":"e202400975","DOI":"10.1002\/cmdc.202400975","volume":"20","author":"D Das","year":"2025","unstructured":"Das D, Wu Y, Hong J (2025) Signaling pathways and promising small-molecule therapeutic agents for ischemic stroke. ChemMedChem 20:e202400975. https:\/\/doi.org\/10.1002\/cmdc.202400975","journal-title":"ChemMedChem"},{"key":"11637_CR12","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1021\/acs.jmedchem.0c00887","volume":"63","author":"J Marco-Contelles","year":"2020","unstructured":"Marco-Contelles J, Zhang Y (2020) From seeds of apium graveolens linn. to a cerebral ischemia medicine: the long journey of 3-n-butylphthalide. J Med Chem 63:12485\u201312510. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00887","journal-title":"J Med Chem"},{"key":"11637_CR13","doi-asserted-by":"publisher","unstructured":"Cui L, Zhu Y, Gao S et al (2013) Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial. Chin Med J 126:3405\u20133410 https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20123240","DOI":"10.3760\/cma.j.issn.0366-6999.20123240"},{"key":"11637_CR14","doi-asserted-by":"publisher","first-page":"963118","DOI":"10.3389\/fphar.2022.963118","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Ye K, Li D et al (2022) DL-3-n-butylphthalide for acute ischemic stroke: an updated systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 13:963118. https:\/\/doi.org\/10.3389\/fphar.2022.963118","journal-title":"Front Pharmacol"},{"key":"11637_CR15","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1021\/acs.jmedchem.0c00887","volume":"63","author":"J Marco-Contelles","year":"2020","unstructured":"Marco-Contelles J, Zhang Y (2020) From seeds of Apium graveolens Linn. to a cerebral ischemia medicine: the long journey of 3- n -butylphthalide. J Med Chem 63:12485\u201312510. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00887","journal-title":"J Med Chem"},{"key":"11637_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09537104.2014.989826","volume":"26","author":"J Ye","year":"2015","unstructured":"Ye J, Zhai L, Zhang S et al (2015) DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase. Platelets 26:736\u2013744. https:\/\/doi.org\/10.3109\/09537104.2014.989826","journal-title":"Platelets"},{"key":"11637_CR17","doi-asserted-by":"publisher","first-page":"120125","DOI":"10.1016\/j.lfs.2021.120125","volume":"287","author":"Y Xue","year":"2021","unstructured":"Xue Y, Ren X, Zhu Z et al (2021) Site-specific protein modification by 3-n-butylphthalide in primary hepatocytes: covalent protein adducts diminished by glutathione and N-acetylcysteine. Life Sci 287:120125. https:\/\/doi.org\/10.1016\/j.lfs.2021.120125","journal-title":"Life Sci"},{"key":"11637_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.brainres.2010.08.043","volume":"1358","author":"Y Gao","year":"2010","unstructured":"Gao Y, Zhang H-W, Qiao H-L et al (2010) Protective effect of 3-butyl-6-bromo-1(3H)-isobenzofuranone on hydrogen peroxide-induced damage in PC12 cells. Brain Res 1358:239\u2013247. https:\/\/doi.org\/10.1016\/j.brainres.2010.08.043","journal-title":"Brain Res"},{"key":"11637_CR19","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.bmcl.2013.02.035","volume":"23","author":"X Wang","year":"2013","unstructured":"Wang X, Wang L, Huang Z et al (2013) Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents. Bioorg Med Chem Lett 23:1985\u20131988. https:\/\/doi.org\/10.1016\/j.bmcl.2013.02.035","journal-title":"Bioorg Med Chem Lett"},{"key":"11637_CR20","doi-asserted-by":"publisher","first-page":"18781","DOI":"10.1039\/D4NJ01760A","volume":"48","author":"J Wang","year":"2024","unstructured":"Wang J, Cao R, Zhao Y et al (2024) Novel hybrids of 6-amino-3- n -butylphthalide and neuroprotective groups against ischemic stroke. New J Chem 48:18781\u201318795. https:\/\/doi.org\/10.1039\/D4NJ01760A","journal-title":"New J Chem"},{"key":"11637_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bmcl.2017.01.050","volume":"27","author":"X Qiang","year":"2017","unstructured":"Qiang X, Li Y, Yang X et al (2017) DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-\u03b2 aggregation and monoamine oxidases with high antioxidant potency for Alzheimer\u2019s therapy. Bioorg Med Chem Lett 27:718\u2013722. https:\/\/doi.org\/10.1016\/j.bmcl.2017.01.050","journal-title":"Bioorg Med Chem Lett"},{"key":"11637_CR22","doi-asserted-by":"publisher","unstructured":"Das D, Xie L , Wang J et al (2020) In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR\/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models. Bioorg Chem 99:103790 https:\/\/doi.org\/10.1016\/j.bioorg.2020.103790","DOI":"10.1016\/j.bioorg.2020.103790"},{"key":"11637_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bmcl.2018.12.056","volume":"29","author":"D Das","year":"2019","unstructured":"Das D, Xie L, Wang J et al (2019) Discovery of new quinazoline derivatives as irreversible dual EGFR\/HER2 inhibitors and their anticancer activities \u2013 Part 1. Bioorg Med Chem Lett 29:591\u2013596. https:\/\/doi.org\/10.1016\/j.bmcl.2018.12.056","journal-title":"Bioorg Med Chem Lett"},{"key":"11637_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1021\/acsmedchemlett.2c00495","volume":"14","author":"D Das","year":"2023","unstructured":"Das D, Qiao D, Liu Z et al (2023) Discovery of Novel, selective prostaglandin EP4 receptor antagonists with efficacy in cancer models. ACS Med Chem Lett 14:727\u2013736. https:\/\/doi.org\/10.1021\/acsmedchemlett.2c00495","journal-title":"ACS Med Chem Lett"},{"key":"11637_CR25","doi-asserted-by":"publisher","first-page":"129971","DOI":"10.1016\/j.bmcl.2024.129971","volume":"113","author":"D Das","year":"2024","unstructured":"Das D, Xie L, Qiao D et al (2024) Discovery of novel, orally bioavailable phenylacetamide derivatives as multikinase inhibitors and in vivo efficacy study in hepatocellular carcinoma animal models. Bioorg Med Chem Lett 113:129971. https:\/\/doi.org\/10.1016\/j.bmcl.2024.129971","journal-title":"Bioorg Med Chem Lett"},{"key":"11637_CR26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1021\/acsmedchemlett.5c00098","volume":"16","author":"D Das","year":"2025","unstructured":"Das D, Xie L, Qiao D et al (2025) Discovery of reversible, noncovalent bruton\u2019s tyrosine kinase inhibitors targeting BTK C481S mutation. ACS Med Chem Lett 16:1038\u20131047. https:\/\/doi.org\/10.1021\/acsmedchemlett.5c00098","journal-title":"ACS Med Chem Lett"},{"key":"11637_CR27","doi-asserted-by":"publisher","first-page":"109617","DOI":"10.1016\/j.bioorg.2026.109617","volume":"173","author":"D Das","year":"2026","unstructured":"Das D, Xie L, Hong J (2026) Expanding landscape of kinase inhibitor research in 25 years (2001\u20132025) and advancements of next-generation kinase inhibitors. Bioorg Chem 173:109617. https:\/\/doi.org\/10.1016\/j.bioorg.2026.109617","journal-title":"Bioorg Chem"},{"key":"11637_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/092986709787002817","volume":"16","author":"S Prasanna","year":"2009","unstructured":"Prasanna S, Doerksen R (2009) Topological polar surface area: a useful descriptor in 2D-QSAR. CMC 16:21\u201341. https:\/\/doi.org\/10.2174\/092986709787002817","journal-title":"CMC"},{"key":"11637_CR29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.ejmech.2010.01.036","volume":"45","author":"W Wang","year":"2010","unstructured":"Wang W, Cha X-X, Reiner J et al (2010) Synthesis and biological activity of n-butylphthalide derivatives. Eur J Med Chem 45:1941\u20131946. https:\/\/doi.org\/10.1016\/j.ejmech.2010.01.036","journal-title":"Eur J Med Chem"},{"key":"11637_CR30","unstructured":"Hong J, Das D, Xie L et al (2025) Isobenzofuran-1(3H)-one derivative and its application; patent CN 120383588 A"},{"key":"11637_CR31","doi-asserted-by":"publisher","first-page":"13458","DOI":"10.1074\/jbc.X120.015651","volume":"295","author":"H Sies","year":"2020","unstructured":"Sies H (2020) Findings in redox biology: from H2O2 to oxidative stress. J Biol Chem 295:13458\u201313473. https:\/\/doi.org\/10.1074\/jbc.X120.015651","journal-title":"J Biol Chem"},{"key":"11637_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41598-018-36769-3","volume":"9","author":"C Anasooya Shaji","year":"2019","unstructured":"Anasooya Shaji C, Robinson BD, Yeager A et al (2019) The tri-phasic role of hydrogen peroxide in blood-brain barrier endothelial cells. Sci Rep 9:133. https:\/\/doi.org\/10.1038\/s41598-018-36769-3","journal-title":"Sci Rep"},{"key":"11637_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12031-009-9285-5","volume":"40","author":"S Zhang","year":"2010","unstructured":"Zhang S, Ye J, Dong G (2010) Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 Cells. J Mol Neurosci 40:311\u2013320. https:\/\/doi.org\/10.1007\/s12031-009-9285-5","journal-title":"J Mol Neurosci"},{"key":"11637_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.phymed.2018.09.207","volume":"52","author":"R Langasco","year":"2019","unstructured":"Langasco R, Fancello S, Rassu G et al (2019) Increasing protective activity of genistein by loading into transfersomes: a new potential adjuvant in the oxidative stress-related neurodegenerative diseases? Phytomedicine 52:23\u201331. https:\/\/doi.org\/10.1016\/j.phymed.2018.09.207","journal-title":"Phytomedicine"},{"key":"11637_CR35","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/ars.2012.4981","volume":"19","author":"C Cornelius","year":"2013","unstructured":"Cornelius C, Crupi R, Calabrese V et al (2013) Traumatic brain injury: oxidative stress and neuroprotection. Antioxid Redox Signal 19:836\u2013853. https:\/\/doi.org\/10.1089\/ars.2012.4981","journal-title":"Antioxid Redox Signal"},{"key":"11637_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1039\/C8MD00472B","volume":"10","author":"L Guan","year":"2019","unstructured":"Guan L, Yang H, Cai Y et al (2019) ADMET-score \u2013 a comprehensive scoring function for evaluation of chemical drug-likeness. Med Chem Commun 10:148\u2013157. https:\/\/doi.org\/10.1039\/C8MD00472B","journal-title":"Med Chem Commun"},{"key":"11637_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s00894-020-04385-6","volume":"26","author":"C Agoni","year":"2020","unstructured":"Agoni C, Olotu FA, Ramharack P, Soliman ME (2020) Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say? J Mol Model 26:120. https:\/\/doi.org\/10.1007\/s00894-020-04385-6","journal-title":"J Mol Model"},{"key":"11637_CR38","doi-asserted-by":"publisher","first-page":"100959","DOI":"10.1016\/j.chphi.2025.100959","volume":"11","author":"M Lahyaoui","year":"2025","unstructured":"Lahyaoui M, El Yaqoubi M, Idrissi HE et al (2025) Design, quantitative structure\u2013activity relationships and computational studies of acylshikonin derivatives: Insights into antitumor activity. Chem Phys Impact 11:100959. https:\/\/doi.org\/10.1016\/j.chphi.2025.100959","journal-title":"Chem Phys Impact"},{"key":"11637_CR39","doi-asserted-by":"publisher","first-page":"107638","DOI":"10.1016\/j.bpc.2026.107638","volume":"335","author":"M Lahyaoui","year":"2026","unstructured":"Lahyaoui M, El Yaqoubi M, Lahyaoui H et al (2026) In silico QSAR-guided design of Dammarane-type triterpenoids as potential PI3K\u03b1-targeted anticancer agents. Biophys Chem 335:107638. https:\/\/doi.org\/10.1016\/j.bpc.2026.107638","journal-title":"Biophys Chem"},{"key":"11637_CR40","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"11637_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V (2016) A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11:1117\u20131121. https:\/\/doi.org\/10.1002\/cmdc.201600182","journal-title":"ChemMedChem"},{"key":"11637_CR42","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB (2015) pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem 58:4066\u20134072. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104","journal-title":"J Med Chem"},{"key":"11637_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-981-10-7757-9_5","volume-title":"Membrane Protein Complexes: Structure and Function","author":"DE Edmondson","year":"2018","unstructured":"Edmondson DE, Binda C (2018) Monoamine Oxidases. In: Harris JR, Boekema EJ (eds) membrane protein complexes: structure and function. Springer Singapore, Singapore, pp 117\u2013139"},{"key":"11637_CR44","doi-asserted-by":"publisher","first-page":"105070","DOI":"10.1016\/j.bioorg.2021.105070","volume":"114","author":"C Zhang","year":"2021","unstructured":"Zhang C, Lv Y, Bai R, Xie Y (2021) Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer\u2019s disease. Bioorg Chem 114:105070. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105070","journal-title":"Bioorg Chem"},{"key":"11637_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11637-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11637-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11637-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:20:31Z","timestamp":1782858031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11637-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":45,"alternative-id":["11637"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11637-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}